The pathophysiology of T2D involves progressive insulin resistance in peripheral tissues, accompanied by β-cell dysfunction and decreased insulin production, ultimately leading to glucose intolerance and metabolic complications [3]. The gene discussed is INS; the disease is type 2 diabetes mellitus.